Image by freepik The composition of gut bacteria can predict which melanoma patients will experience cancer recurrence after surgical resection and immunotherapy, but only when matched to patients with similar microbial profiles, according to research published April 17 in Cell. The findings from a 674-patient international clinical trial offer a novel approach to stratifying recurrence risk in high-risk melanoma patients undergoing adjuvant immune checkpoint blockade. Resear

Photo by engin akyurt on Unsplash In a discovery that could reshape the way scientists and consumers alike think about the connection...

Researchers have found a potential link between the skin microbiota and keloid scarring, which suggests that commensal bacteria and...

Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...

Findings from a pilot study suggest the skin microbiome plays an important role in the risk of radiodermatitis associated with cancer...

Sun-seeking behaviour on holiday can impact the skin microbiota, new research has found. In the study, published in Frontiers in Aging,...

A study involving 50 patients with leukemia who underwent stem cell transplants for the treatment of leukemia indicates a subset of...

Sharing of the microbiome through skin contact between children with atopic dermatitis (AD) and their caregivers may contribute to...